Treatment for Calcium Phosphate Kidney Stone Disease
| Status: | Recruiting |
|---|---|
| Conditions: | Nephrology |
| Therapuetic Areas: | Nephrology / Urology |
| Healthy: | No |
| Age Range: | 21 - Any |
| Updated: | 11/17/2018 |
| Start Date: | July 2012 |
| End Date: | July 2021 |
| Contact: | Ann Heard-Sakhaee, RN |
| Email: | ann.heard-sakhaee@utsouthwestern.edu |
| Phone: | 214-648-4893 |
Pharmacological Therapy for Calcium Phosphate Urolithiasis
The investigators will examine in two studies whether citric acid or potassium citrate can
reduce calcium phosphate saturation in urine of Calcium Phosphate stone formers.
reduce calcium phosphate saturation in urine of Calcium Phosphate stone formers.
We will examine in two short-term placebo-controlled cross-over metabolic studies whether
citric acid or potassium citrate can reduce calcium phosphate saturation in urine of CaP
stone formers. The first study will be conducted in hypocitraturic CaP stone formers without
hypercalciuria, and will compare the effects of potassium citrate, citric acid and placebo.
The second study will be conducted in hypercalciuric CaP stone formers on a thiazide diuretic
who require potassium supplementation, and will compare the effects of potassium chloride
alone, potassium chloride + citric acid, and potassium citrate alone. Physicochemical assays
will be applied in addition to computer-based stone risk prediction programs to assess risk
of stone recurrence.
citric acid or potassium citrate can reduce calcium phosphate saturation in urine of CaP
stone formers. The first study will be conducted in hypocitraturic CaP stone formers without
hypercalciuria, and will compare the effects of potassium citrate, citric acid and placebo.
The second study will be conducted in hypercalciuric CaP stone formers on a thiazide diuretic
who require potassium supplementation, and will compare the effects of potassium chloride
alone, potassium chloride + citric acid, and potassium citrate alone. Physicochemical assays
will be applied in addition to computer-based stone risk prediction programs to assess risk
of stone recurrence.
Inclusion Criteria:
Aim 1
- Hypocitraturic CaP stone formers
- urine citrate <320mg/d
- elevated pH as 24-hr urine pH above 6.40
- >21 years
Aim 2
- Hypercalciuric CaP stone formers
- 24hr urine calcium >250mg/d in women and >300mg/d in men prior to indapamide use
- high pH as >6.40 in the absence of urinary tract infection
- >21 years
We found this trial at
1
site
U.T. Southwestern Medical Center The story of UT Southwestern Medical Center is one of commitment...
Click here to add this to my saved trials
